Business

January 3, 2014

FDA cites Dara BioSciences for misleading marketing of Soltamox

Federal regulators have cited Raleigh-based Dara BioSciences for running misleading sales aids for Soltamox, an oral liquid formulation used in the treatment and prevention of breast cancer.

Related content

Comments

Videos

Editor's Choice Videos